Gannex Pharma Co., Ltd.

Calculating rank

USPTO Granted Patents = 6

Forward Citations = 4

Loading Chart...

7 inventors (with patents filed for the assignee):

Jinzi Jason Wu (5 out of 6 patents)

Bailing Yang (4 out of 6 patents)

Bin Liang (3 out of 6 patents)

4. Xuyu Chai (2 out of 2 patents)

5. James Chen (1 out of 5 patents)

6. Gudmundsson Kristjan (1 out of 1 patent)

7. Liuyu Dong (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12600716 - Compounds for modulating activity of FXR and uses thereof (2026-04-14),

2. 12084469 - Preparation method of a cyclic phosphonate compound (2024-09-10),

3. 11752161 - Pharmaceutical compositions, method of making and method of using thereof (2023-09-12),

4. 11725019 - Preparation method of a cyclic phosphonate compound (2023-08-15),

5. 11583502 - Pharmaceutical compositions comprising a thyroid hormone beta agonist, method of use and method making thereof (2023-02-21),

6. 11292805 - Preparation method of a cyclic phosphonate compound (2022-04-05),

Company Overview

Gannex Pharma Co., Ltd. is a leading pharmaceutical company focused on developing innovative therapies for various diseases. With a strong commitment to research and development, Gannex Pharma is dedicated to improving patients' lives through the creation of high-quality and affordable medications. Their portfolio includes a range of products in areas such as oncology, immunology, and rare diseases. Visit their website to learn more about their products and pipeline.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

6 Patents

#393 in Shanghai

#4,483 in China

Shanghai, China